Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Picard

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
European Journal of Endocrinology|May 12, 2009
Sex hormone-binding globulin predicts the incidence of hyperglycemia in women: interactions with adiponectin levelsF Bonnet, B Balkau, J M Malécot, et al.
Cardiovascular Research|December 12, 2001
Administration of exogenous endothelin-1 following vascular balloon injury: early and late effects on intimal hyperplasiaA W Barolet, S Babaei, R Robinson, et al.
European Journal of Pain (London, England)|March 27, 2018
Efficacy and safety of a T-type calcium channel blocker in patients with neuropathic pain: A proof-of-concept, randomized, double-blind and controlled trialN Kerckhove, B Pereira, S Soriot-Thomas, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
European Journal of Endocrinology|May 12, 2009
Sex hormone-binding globulin predicts the incidence of hyperglycemia in women: interactions with adiponectin levelsF Bonnet, B Balkau, J M Malécot, et al.
Cardiovascular Research|December 12, 2001
Administration of exogenous endothelin-1 following vascular balloon injury: early and late effects on intimal hyperplasiaA W Barolet, S Babaei, R Robinson, et al.
European Journal of Pain (London, England)|March 27, 2018
Efficacy and safety of a T-type calcium channel blocker in patients with neuropathic pain: A proof-of-concept, randomized, double-blind and controlled trialN Kerckhove, B Pereira, S Soriot-Thomas, et al.
Pageof 9